Evidence map›Paper›PMID 30639589›Full record

ArticleThe spine journal : official journal of the North American Spine Society2019

Trends in lumbar radiofrequency ablation utilization from 2007 to 2016.

Jordan B Starr, Laurie Gold, Zachary McCormick, Pradeep Suri, Janna Friedly

2 registry-linked trialsOpen access · greenAbstract read
In one paragraph

Article in The spine journal : official journal of the North American Spine Society, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06804551 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

A Single-center, Prospective, Double-blind, Randomized Controlled Trial Evaluating Iovera° Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Facet-mediated Chronic Low Back Pain

TypeinterventionalSponsorUniversity of Kansas Medical CenterRan2025 to 2027Enrolled30ConditionsChronic Low-back PainArmsiovera system, Radiofrequency ablation alone
NCT07214844 narecruitingnot on this mapstarted 2026, after this paper: background citation

A Prospective, Randomized, Assessor Blind, Active-controlled, Single-center Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Facet-mediated Chronic Low Back Pain

TypeinterventionalSponsorMontefiore Medical CenterRan2026 to 2028Enrolled110ConditionsLow Back Pain, ChronicArmsIovera Medial Branch Cryoneurolysis, Radiofrequency ablation (RFA)
3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it, 62 citations in OpenAlex.

  1. Pooled it
  2. Percutaneous radiofrequency ablation and endoscopic neurotomy for lumbar facet joint syndrome: are they good enough?European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2024
    Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Jordan B StarrDepartment of Anesthesiology and Pain Medicine, University of Washington, Box 356540, Seattle, WA 98195, USA. Electronic address: starrj@uw.edu.
Laurie GoldCLEAR Center, University of Washington, Box 359455, Seattle, WA 98195, USA.
Zachary McCormickDivision of Physical Medicine and Rehabilitation, University of Utah, 30 North 1900 East, Salt Lake City, UT 84132, USA.
Pradeep SuriDepartment of Rehabilitation Medicine, University of Washington, Box 359612, Seattle, WA 98104, USA; Rehabilitation Care Services, VA Puget Sound Health Care System, 1660 South Columbian Way, Seattle, WA, 98108, USA.
Janna FriedlyDepartment of Rehabilitation Medicine, University of Washington, Box 359612, Seattle, WA 98104, USA.
University of Washington · USUniversity of Utah · US

Funding

UW Core Center for Clinical Research of Musculoskeletal ConditionsP30AR072572 · NIAMS · UNIVERSITY OF WASHINGTON · PI JEFFREY G JARVIK, Pradeep Suri · 2017 to 2026
$8.3M
NIAMS NIH HHS P30 AR072572
6 · The paper itself

Abstract

background contextLumbar radiofrequency ablation (RFA) is an intervention used to treat facet-mediated chronic low back pain. In some studies with methods consistent with clinical practice guidelines, RFA results in improvements in pain and functional limitations. However, in other studies, RFA demonstrates limited benefit. Despite unanswered questions regarding efficacy of RFA, its use is widespread. PURPOSE: To describe trends in the utilization and cost of lumbar RFA and lumbar facet injections. STUDY DESIGN/

settingRetrospective cohort study. PATIENT SAMPLE: The sample was derived from the IBM/Watson MarketScan Commercial Claims and Encounters Databases from 2007 to 2016. OUTCOME MEASURES: Longitudinal trends in the distribution and quantity of lumbar facet injections before lumbar RFA, corticosteroid administration during lumbar facet injections, progression to lumbar RFA after lumbar facet injections, lumbar RFA utilization, and costs of these interventions.

methodsTwo primary cohorts were identified from patients who received lumbar RFA or lumbar facet injection procedures. Utilization rates per 100,000 enrollees were determined for both cohorts. The mean, median, and interquartile ranges of the number of facets targeted and costs per procedure were calculated by year and laterality, as well as overall. Costs in 2018 dollars were estimated by summing gross payment totals from patients and insurance plans. This study was supported by funds from the NIH, and has no conflict of interest associated biases.

resultsFrom 2007 to 2016, lumbar RFA sessions performed per 100,000 enrollees per year increased from 49 to 113, a 130.6% overall increase (9.7% annually). Lumbar facet injection use increased from 201 to 251 sessions per 100,000 enrollees, a 24.9% overall increase (2.5% annually). In the year after a lumbar facet injection, 26.7% of patients received lumbar RFA; 28.6% received another injection but not RFA; and 44.7% received neither. The number of patients receiving two lumbar facet injection procedures prior to lumbar RFA grew from 51.1% in 2010 to 58.8% in 2016. For lumbar RFA, the cost per 100,000 enrollees went from $94,570 in 2007 to $266,680 in 2016, a 12.2% annual increase. For lumbar facet injections, the cost per 100,000 enrollees went from $257,280 in 2007 to $396,580 in 2016, a 4.9% annual increase.

conclusionsThis analysis showed consistent growth in both the frequency and procedure cost of lumbar RFA and facet injections among a large, national, commercially insured population from 2007 to 2016.

Indexed as

AdultCosts and Cost AnalysisFacilities and Services UtilizationFemaleHumansLow Back PainLumbosacral RegionMaleMiddle AgedRadiofrequency AblationCosts and cost analysisDatabaseInjectionsProcedures and techniques utilizationRadiofrequency ablationZygapophyseal joint

Identifiers

PMID30639589
PMCPMC6534485
OpenAlexW2908781968

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.